• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

肝细胞腺瘤：最新进展

Hepatocellular adenomas: recent updates.

作者信息

Kim Haeryoung, Park Young Nyun

机构信息

Department of Pathology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.

Department of Pathology, Graduate School of Medical Science, Brain Korea 21 Project, Yonsei University College of Medicine, Seoul, Korea.

出版信息

J Pathol Transl Med. 2021 May;55(3):171-180. doi: 10.4132/jptm.2021.02.27. Epub 2021 Apr 7.

DOI:10.4132/jptm.2021.02.27
PMID:33823565
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8141970/
Abstract

Hepatocellular adenoma (HCA) is a heterogeneous entity, from both the histomorphological and molecular aspects, and the resultant subclassification has brought a strong translational impact for both pathologists and clinicians. In this review, we provide an overview of the recent updates on HCA from the pathologists' perspective and discuss several practical issues and pitfalls that may be useful for diagnostic practice.

摘要

肝细胞腺瘤（HCA）在组织形态学和分子层面均为异质性实体，由此产生的亚分类对病理学家和临床医生都产生了重大的转化医学影响。在本综述中，我们从病理学家的角度概述了HCA的最新进展，并讨论了一些对诊断实践可能有用的实际问题和陷阱。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1453/8141970/e8ac70823403/jptm-2021-02-27f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1453/8141970/b35ee59bb430/jptm-2021-02-27f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1453/8141970/6a4fdb87be5c/jptm-2021-02-27f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1453/8141970/71272cf5dd23/jptm-2021-02-27f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1453/8141970/6bc989ff2042/jptm-2021-02-27f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1453/8141970/cf7669c8639d/jptm-2021-02-27f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1453/8141970/e8ac70823403/jptm-2021-02-27f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1453/8141970/b35ee59bb430/jptm-2021-02-27f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1453/8141970/6a4fdb87be5c/jptm-2021-02-27f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1453/8141970/71272cf5dd23/jptm-2021-02-27f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1453/8141970/6bc989ff2042/jptm-2021-02-27f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1453/8141970/cf7669c8639d/jptm-2021-02-27f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1453/8141970/e8ac70823403/jptm-2021-02-27f6.jpg

相似文献

1
Hepatocellular adenomas: recent updates.肝细胞腺瘤：最新进展
J Pathol Transl Med. 2021 May;55(3):171-180. doi: 10.4132/jptm.2021.02.27. Epub 2021 Apr 7.
2
Subclassification of hepatocellular adenomas: practical considerations in the implementation of the Bordeaux criteria.肝细胞腺瘤的分类：实施波尔多标准的实用考虑。
Pathology. 2018 Oct;50(6):593-599. doi: 10.1016/j.pathol.2018.05.003. Epub 2018 Aug 24.
3
Molecular classification of hepatocellular adenoma in clinical practice.肝细胞腺瘤的临床分子分类。
J Hepatol. 2017 Nov;67(5):1074-1083. doi: 10.1016/j.jhep.2017.07.009. Epub 2017 Jul 19.
4
Gene mutations in hepatocellular adenomas.肝细胞腺瘤中的基因突变。
Histopathology. 2015 Jun;66(7):910-21. doi: 10.1111/his.12539. Epub 2014 Oct 30.
5
Revisiting the pathology of resected benign hepatocellular nodules using new immunohistochemical markers.重新审视使用新免疫组织化学标志物的切除良性肝细胞结节的病理学。
Semin Liver Dis. 2011 Feb;31(1):91-103. doi: 10.1055/s-0031-1272837. Epub 2011 Feb 22.
6
Update on hepatocellular carcinoma: Pathologists' review.肝细胞癌最新进展：病理学家述评。
World J Gastroenterol. 2019 Apr 14;25(14):1653-1665. doi: 10.3748/wjg.v25.i14.1653.
7
Molecular Classification of Hepatocellular Adenoma Associates With Risk Factors, Bleeding, and Malignant Transformation.肝细胞腺瘤的分子分类与危险因素、出血和恶性转化相关。
Gastroenterology. 2017 Mar;152(4):880-894.e6. doi: 10.1053/j.gastro.2016.11.042. Epub 2016 Dec 7.
8
Hepatocellular adenoma: Classification, variants and clinical relevance.肝细胞腺瘤：分类、变异型及临床相关性。
Semin Diagn Pathol. 2017 Mar;34(2):112-125. doi: 10.1053/j.semdp.2016.12.007. Epub 2016 Dec 20.
9
Hepatocellular adenomas in a large community population, 2000 to 2010: reclassification per current World Health Organization classification and results of long-term follow-up.2000 年至 2010 年大社区人群中的肝细胞腺瘤：根据当前世界卫生组织分类进行重新分类及长期随访结果。
Hum Pathol. 2014 May;45(5):976-83. doi: 10.1016/j.humpath.2013.12.011. Epub 2014 Jan 8.
10
New MRI features improve subtype classification of hepatocellular adenoma.新的 MRI 特征可改善肝细胞腺瘤的亚型分类。
Eur Radiol. 2019 May;29(5):2436-2447. doi: 10.1007/s00330-018-5784-5. Epub 2018 Dec 6.

引用本文的文献

1
Prognostic role of selection criteria for liver transplantation in patients with hepatocellular carcinoma: Review and bibliometric.肝细胞癌患者肝移植选择标准的预后作用：综述与文献计量学分析
ILIVER. 2024 Feb 6;3(1):100077. doi: 10.1016/j.iliver.2024.100077. eCollection 2024 Mar.
2
Hepatocellular adenoma update: diagnosis, molecular classification, and clinical course.肝细胞腺瘤更新：诊断、分子分类和临床过程。
Br J Radiol. 2024 Nov 1;97(1163):1740-1754. doi: 10.1093/bjr/tqae180.
3
Estrobolome and Hepatocellular Adenomas-Connecting the Dots of the Gut Microbial β-Glucuronidase Pathway as a Metabolic Link.

本文引用的文献

1
Multiple hepatocyte nuclear factor 1A (HNF1A)-inactivated hepatocellular adenomas arising in a background of congenital hepatic fibrosis.在先天性肝纤维化背景下出现的多个肝细胞核因子1A（HNF1A）失活的肝细胞腺瘤。
J Pathol Transl Med. 2021 Mar;55(2):154-158. doi: 10.4132/jptm.2020.11.12. Epub 2020 Dec 23.
2
ASS1 Overexpression: A Hallmark of Sonic Hedgehog Hepatocellular Adenomas; Recommendations for Clinical Practice.ASS1过表达： Sonic Hedgehog肝细胞腺瘤的一个标志；临床实践建议
Hepatol Commun. 2020 Apr 11;4(6):809-824. doi: 10.1002/hep4.1514. eCollection 2020 Jun.
3
Hepatocellular adenoma in Taiwan: Distinct ensemble of male predominance, overweight/obesity, and inflammatory subtype.
肠微生物β-葡萄糖醛酸苷酶途径作为代谢联系将 Estrobolome 和肝细胞腺瘤联系起来。
Int J Mol Sci. 2023 Nov 7;24(22):16034. doi: 10.3390/ijms242216034.
4
Advances in Histological and Molecular Classification of Hepatocellular Carcinoma.肝细胞癌组织学和分子分类的进展
Biomedicines. 2023 Sep 20;11(9):2582. doi: 10.3390/biomedicines11092582.
5
A Case Report on a Giant Hepatic Inflammatory Adenoma in a Young Female That Presented as Spontaneous Intrahepatic Hematoma.一例以自发性肝内血肿形式出现的年轻女性巨大肝脏炎性腺瘤病例报告。
Cureus. 2023 Jul 18;15(7):e42055. doi: 10.7759/cureus.42055. eCollection 2023 Jul.
台湾的肝细胞腺瘤：以男性为主、超重/肥胖和炎症亚型为特征的独特组合。
J Gastroenterol Hepatol. 2020 Apr;35(4):680-688. doi: 10.1111/jgh.14903. Epub 2019 Nov 7.
4
Unclassified hepatocellular adenoma expressing ASS1 associated with inflammatory hepatocellular adenomas.表达ASS1的未分类肝细胞腺瘤与炎症性肝细胞腺瘤相关。
Clin Res Hepatol Gastroenterol. 2019 Oct;43(5):e63-e67. doi: 10.1016/j.clinre.2019.03.012. Epub 2019 Apr 30.
5
Hepatocellular adenomas: one step beyond.肝细胞腺瘤：更进一步
Gut. 2019 Jul;68(7):1140-1142. doi: 10.1136/gutjnl-2019-318299. Epub 2019 Apr 9.
6
A difficult case of β-catenin-mutated hepatocellular adenoma: a lesson for diagnosis.一例β-连环蛋白突变型肝细胞腺瘤的疑难病例：诊断经验教训
Histopathology. 2019 Jan;74(2):355-357. doi: 10.1111/his.13751. Epub 2018 Dec 6.
7
C-reactive Protein Overexpression in the Background Liver of Hepatitis B Virus-Associated Hepatocellular Carcinoma Is a Prognostic Biomarker.C反应蛋白在乙型肝炎病毒相关肝细胞癌背景肝组织中的过表达是一种预后生物标志物。
J Pathol Transl Med. 2018 Sep;52(5):267-274. doi: 10.4132/jptm.2018.07.14. Epub 2018 Jul 27.
8
Hepatocellular nodules in vascular liver diseases.血管性肝脏疾病中的肝细胞结节。
Virchows Arch. 2018 Jul;473(1):33-44. doi: 10.1007/s00428-018-2373-6. Epub 2018 May 26.
9
Hepatic Adenomas: Classification, Controversies, and Consensus.肝腺瘤：分类、争议与共识
Surg Pathol Clin. 2018 Jun;11(2):351-366. doi: 10.1016/j.path.2018.02.007. Epub 2018 Mar 26.
10
Atypical Hepatocellular Neoplasms: Review of Clinical, Morphologic, Immunohistochemical, Molecular, and Cytogenetic Features.非典型肝细胞肿瘤：临床、形态、免疫组化、分子和细胞遗传学特征综述。
Adv Anat Pathol. 2018 Jul;25(4):254-262. doi: 10.1097/PAP.0000000000000189.